T. Rowe Price Investment Management, Inc. - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$210,204
+20.0%
8,324,884
+0.2%
0.15%
+25.2%
Q2 2023$175,222
+22.1%
8,304,314
-1.3%
0.12%
+15.5%
Q1 2023$143,484
-14.2%
8,415,430
+0.5%
0.10%
-19.5%
Q4 2022$167,327
-99.9%
8,374,675
+3.8%
0.13%
-7.9%
Q3 2022$173,759,0008,066,7620.14%
Other shareholders
INSMED INC shareholders Q3 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$148,709,64814.07%
Deep Track Capital, LP 6,000,000$151,500,0005.85%
Octagon Capital Advisors LP 1,284,000$32,421,0004.98%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,446,334$87,019,9344.70%
MPM BioImpact LLC 527,458$13,318,3153.56%
Novo Holdings A/S 1,339,304$33,817,4262.50%
Bleichroeder LP 325,000$8,206,2502.02%
GREAT POINT PARTNERS LLC 394,872$9,970,5181.82%
Endurant Capital Management LP 79,471$2,006,6431.80%
SECTORAL ASSET MANAGEMENT INC 347,392$8,771,6481.71%
View complete list of INSMED INC shareholders